1. Home /
  2. Life Sciences

Life Sciences

Edwards Lifesciences Sends Positive Signals but Merits Wait-and-See Approach

The charts of the producer of medical technology show promise but could be derailed by weakness in the broader markets.

I've Got a Rough Floorplan for How to Play Blueprint Medicines

The charts for this drug developer are starting to take shape.

Edwards Lifesciences Offers Promise for Patients and Investors

Traders have been shifting from aggressive selling to aggressive buying.

This Won't Hurt a Bit: Moderna Could Rally 25% From Here

The stock is ready to make a recovery rally.

Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?

Let's check the charts on this biotechnology stock and see if it still has a prayer.

Little-Known Akoya Biosciences Appears to Have Found a Bottom

The stock of the life sciences company has found buying interest at a key support level.

Treat Becton, Dickinson and Company With Care

BDX gets an upgrade, but are the charts healthy enough to recommend?

Johnson & Johnson Appears to Be Running Out of Steam

The shares of the healthcare giant have been in a long-term uptrend but could break that trend in the weeks ahead.

Bearish Bets: 3 Stocks You Should Consider Shorting This Week

These recently downgraded names are displaying both quantitative and technical deterioration.

Medtronic Shares Appear to Be Bottoming

Aggressive traders of the medical device maker's stock could probe the long side on weakness, such as it is seeing after posting fiscal fourth-quarter results.